Article Information
- Received January 12, 2011
- Revision received March 31, 2011
- Accepted April 5, 2011
- First published May 18, 2011.
- Version of record published May 18, 2011.
Author Information
- Estefanía Moreno1,2,*,
- Sandra H. Vaz3,4,*,
- Ning-Sheng Cai5,
- Carla Ferrada1,2,
- César Quiroz5,
- Sandeep Kumar Barodia5,
- Nadine Kabbani6,
- Enric I. Canela1,2,
- Peter J. McCormick1,2,
- Carme Lluis1,2,
- Rafael Franco1,2,7,
- Joaquim A. Ribeiro3,4,
- Ana M. Sebastião3,4,**, and
- Sergi Ferré5,**
- 1Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas and
- 2Faculty of Biology, Department of Biochemistry and Molecular Biology, University of Barcelona, 08028 Barcelona, Spain,
- 3Faculty of Medicine, Institute of Pharmacology and Neurosciences, and
- 4Unit of Neuroscience, Institute of Molecular Medicine, University of Lisbon, 1649-028 Lisbon, Portugal,
- 5Intramural Research Program, National Institute on Drug Abuse, Department of Health and Human Services, National Institutes of Health, Baltimore, Maryland 21224,
- 6Department of Molecular Neuroscience, Krasnow Institute for Advanced Study, Fairfax, Virginia 22030, and
- 7Centro de Investigación Médica Aplicada, Universidad de Navarra, 31008 Pamplona, Spain
Author contributions
Author contributions: N.K., E.I.C., P.J.M., C.L., R.F., J.A.R., A.M.S., and S.F. designed research; E.M., S.H.V., N.-S.C., C.F., and S.B. performed research; E.M., S.H.V., N.-S.C., C.Q., S.B., C.L., A.M.S., and S.F. analyzed data; P.J.M., C.L., J.A.R., A.M.S., and S.F. wrote the paper.
↵*E.M. and S.H.V. contributed equally to this work.
↵**A.M.S. and S.F. contributed equally to this work.
Disclosures
- Received January 12, 2011.
- Revision received March 31, 2011.
- Accepted April 5, 2011.
This work was supported by the Spanish Ministerio de Ciencia y Tecnología (Grants SAF2008-03229-E, SAF2009-07276 and SAF2010-18472), the intramural funds of the National Institute on Drug Abuse, EU (Cost B-30 concerted action), and Fundação para a Ciência e Tecnologia (FCT, Portugal). S.H.V. is in receipt of a FCT PhD fellowship (SFRHBD/27989/2006). P.J.M. is a Ramon y Cajal Investigator. We acknowledge the technical help obtained from Jasmina Jiménez (Molecular Neurobiology laboratory, Barcelona University, Barcelona).
The authors declare no competing financial interests.
- Correspondence should be addressed to Sergi Ferré, National Institute on Drug Abuse, Intramural Research Program, Department of Health and Human Services, NIH, 251 Bayview Boulevard, Baltimore MD 21224. sferre{at}intra.nida.nih.gov
Online Impact